GlassScriptPhysician profile
Julianne R Garrison
NPI 1902952518
$2,853.41
in general payments reported to CMS, 2019-2025
32 companies · $16.10 in 2025
The $16.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $999 · 2021: $1,161 · 2023: $35.93 · 2025: $16.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $507.63 | 2019-2021 | |
| Allergan, INC. | $346.46 | 2019-2021 | |
| Amgen INC. | $259.87 | 2019-2021 | |
| Novo Nordisk INC | $251.17 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $221.67 | 2019-2021 | |
| Lilly USA, LLC | $172.62 | 2019-2021 | |
| Glaxosmithkline, LLC. | $112.83 | 2019-2025 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $105.89 | 2019-2021 | |
| Lucid Diagnostics INC. | $93.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $91.88 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $87.85 | 2019-2021 | |
| Pfizer INC. | $70.15 | 2019-2021 | |
| Eisai INC. | $64.52 | 2021 | |
| Sanofi Pasteur INC. | $51.92 | 2020 | |
| Bausch Health US, LLC | $47.42 | 2020-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $42.34 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.39 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $29.37 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.91 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.27 | 2020-2021 | |
| Neos Therapeutics, LP | $22.67 | 2019 | |
| Astellas Pharma US INC | $22.30 | 2021 | |
| Daiichi Sankyo INC. | $22.09 | 2019 | |
| Exact Sciences Corporation | $21.67 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.93 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.77 | 2021 | |
| Dermira, INC. | $16.99 | 2020 | |
| Shire North American Group INC | $14.79 | 2019 | |
| Seqirus USA INC | $14.29 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.26 | 2023 | |
| Assertio Therapeutics, INC. | $12.20 | 2019 | |
| Amarin Pharma, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julianne Garrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.